ISPC ISPECIMEN INC

iSpecimen Named to Fast Company’s World’s Most Innovative Companies Annual List for 2023

iSpecimen Named to Fast Company’s World’s Most Innovative Companies Annual List for 2023

Award Highlights Businesses at the Forefront of Innovation That Are Transforming Industries and Shaping Society

LEXINGTON, Mass., March 02, 2023 (GLOBE NEWSWIRE) -- (Nasdaq: ISPC), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers (“iSpecimen”), has been named to Fast Company’s annual list of the as part of the biotech category for 2023. Fast Company is a business magazine that focuses on technology, business and design.

“Every day, healthcare institutions are throwing away valuable biospecimens they no longer need. However, what ends up disposed can actually serve as valuable resources for medical researchers in need of these types of biospecimens,” said Tracy Curley, CEO of iSpecimen. “Our team has worked tirelessly to solve this disconnect and eliminate the cumbersome and time-consuming process for researchers, who are our customers, to obtain this critical biomaterial. Being named to Fast Company’s World’s Most Innovative Companies list is a testament to our continued success in working to reinvent the biospecimen procurement process that will in turn help to further accelerate medical discovery.”

The iSpecimen Marketplace® allows life science researchers to search for and find millions of human biospecimens across iSpecimen’s global, proprietary network of healthcare providers, who have access to large, diverse patient populations and specimens. iSpecimen’s proprietary, cloud-based technology enables scientists to intuitively search via a Google-like search bar for biospecimens based on demographic traits, medical conditions, procedures, blood type, country of collection and much more.

iSpecimen addresses the highly fragmented and inefficient biospecimen procurement market that makes compliance and contracting increasingly complex and challenging for researchers to manage themselves. The iSpecimen Marketplace compliantly connects each side of this fragmented market to reduce the costs, time and risks for both suppliers and customers in the biospecimen supply chain.

The World’s Most Innovative Companies is Fast Company’s signature franchise and one of its most highly anticipated editorial efforts of the year. Fast Company will host its third annual on April 19-20, 2023. The virtual summit celebrates the Most Innovative Companies in business and provides an inside look at cutting-edge business trends and what it takes to innovate in 2023. Fast Company’s Most Innovative Companies issue (March/April 2023) is available online, as well as in-app form via iTunes, and on newsstands beginning March 14, 2023.

About iSpecimen

iSpecimen (Nasdaq: ISPC) offers an online marketplace for human biospecimens, connecting scientists in commercial and non-profit organizations with healthcare providers that have access to patients and specimens needed for medical discovery. Proprietary, cloud-based technology enables scientists to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers and other healthcare organizations. For more information, please visit .

For further information, please contact:

Investor Contact

KCSA Strategic Communications

Allison Soss

Media Contacts

KCSA Strategic Communications

Raquel Cona / Michaela Fawcett



EN
02/03/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ISPECIMEN INC

 PRESS RELEASE

iSpecimen Releases Cancer Biospecimen Offering; Orders Anticipated of ...

iSpecimen Releases Cancer Biospecimen Offering; Orders Anticipated of Over $9,500,000 Annually WOBURN, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) --  (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today a significant enhancement to its searchable inventory that provides researchers with increased access to a wide array of biospecimens vital to advancing oncology research and treatments. The expanded inventory includes highly sought-afte...

 PRESS RELEASE

iSpecimen Reports Third Quarter 2024 Results

iSpecimen Reports Third Quarter 2024 Results LEXINGTON, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) --  (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today reported its financial and operating results for the three and nine month periods ended September 30, 2024. "The third quarter was a period of continued strategic transformation for iSpecimen, primarily driven by several key initiatives," said Tracy Curley, CEO of iSpecimen. "First, we completed...

 PRESS RELEASE

iSpecimen Inc. Announces Closing of $5 Million Public Offering of Comm...

iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants WOBURN, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) --  (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today the closing of its previously announced public offering of approximately $5 million of the Company’s common stock and pre-funded warrants to purchase shares of common stock at a public offering price of $3.00 per share (minus $0.000...

 PRESS RELEASE

iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Comm...

iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants WOBURN, Mass., Oct. 30, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today the pricing of its public offering of approximately $5 million of the Company’s common stock, and/or pre-funded warrants to purchase shares of common stock at a public offering price of $3.00 per share (minus $0.0001 p...

 PRESS RELEASE

iSpecimen Secures $1 Million Loan; Appoints Three New Board Members

iSpecimen Secures $1 Million Loan; Appoints Three New Board Members WOBURN, Mass., Sept. 26, 2024 (GLOBE NEWSWIRE) --  (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today that it has secured a $1 million loan agreement and subsequently appointed three new members to its Board of Directors. On September 25, 2024, iSpecimen closed a $1 million loan agreement with a lender which carries an interest rate of 18% per annum and is pa...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch